Advanced Therapy Conundrum: Should You Build, Outsource Or Go Hybrid

Source: Outsourced Pharma

Companies developing advanced therapies have to decide early on: Build capacity, and how much? Outsource, and how little? Mix and Match, and how effective? Fortunately, there are guiding principles and best practices for getting these individual assessments right.

Don't have time to watch the full video? Check out these segments by topic: